Legal status CA: Schedule II Molar mass 396,46 g/mol | Formula C23H25FN2O3 3D model (Jmol) Interactive image | |
 | ||
MDMB-FUBICA is an indole-based synthetic cannabinoid that is presumed to be a potent agonist of the CB1 receptor and has been sold online as a designer drug.
Contents
It was first detected by the EMCDDA in Sweden in February 2015.
Side effects
MDMB-FUBICA's indazole analogue MDMB-FUBINACA has been linked to at least 1000 hospitalisations and 40 deaths as a consequence of intoxication as of March 2015.
Legality
MDMB-FUBICA is banned in Sweden.
References
MDMB-FUBICA Wikipedia(Text) CC BY-SA